Nuclear safety validation for the design fuel loading of the subcritical assembly core with the tungsten target
Nuclear Physics and Atomic Energy · 25.06.2026 · 27 (2) · 165-171
DOI: 10.15407/jnpae2026.02.165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Physics and Atomic Energy, online erschienen am 25.06.2026. Verfasst von I.M. Karnaukhov und 7 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
The influence of model parameters for the subcritical assembly core of the subcritical nuclear facility "Neutron Source" and uncertainties of nuclear reaction cross sections on the values of the effective neutron multiplication factor is investigated. The analysis is based on numerical simulation using the international software code MCNP 6.2. The possibility of achieving the design nuclear fuel load of 38 fuel assemblies for the subcritical assembly core with the tungsten neutron-generating target is shown with the justification of nuclear safety.
Zitieren
APA
Karnaukhov, I., Zelinsky, A., Mytsykov, A., Gladkikh, P., Gann, V., Borts, B., Bykov, V., & Ushakov, I. (2026). Nuclear safety validation for the design fuel loading of the subcritical assembly core with the tungsten target. Nuclear Physics and Atomic Energy, 27(2), 165-171. https://doi.org/10.15407/jnpae2026.02.165
Vancouver
Karnaukhov I, Zelinsky A, Mytsykov A, Gladkikh P, Gann V, Borts B, et al. Nuclear safety validation for the design fuel loading of the subcritical assembly core with the tungsten target. Nuclear Physics and Atomic Energy. 2026;27(2):165-171. doi:10.15407/jnpae2026.02.165
BibTeX
@article{Karnaukhov2026,
author = {Karnaukhov, I.M. and Zelinsky, A.Yu. and Mytsykov, A.O. and Gladkikh, P.I. and Gann, V.V. and Borts, B.V. and Bykov, V.T. and Ushakov, I.V.},
title = {Nuclear safety validation for the design fuel loading of the subcritical assembly core with the tungsten target},
journal = {Nuclear Physics and Atomic Energy},
year = {2026},
volume = {27},
number = {2},
pages = {165--171},
doi = {10.15407/jnpae2026.02.165}
}
EUVIMED